Hanool Pyroxicam Injection

Adult administration

Adults: Administer piroxicam 20 mg intramuscularly once daily. The maximum recommended daily dose is 20 mg of piroxicam. To reduce the risk of adverse reactions, use the lowest effective dose for the shortest duration. Therapeutic effect and tolerability should be reviewed within 14 days after administration of this drug. If continued treatment is considered necessary, more frequent reviews should be conducted. The oral formulation or suppository of this drug may be used concomitantly, but the total dose administered by both routes must not exceed the maximum recommended daily dose.

Patients who regularly consume more than three alcoholic beverages per day should consult with a doctor or pharmacist before use, as concurrent use with alcohol may cause gastrointestinal bleeding. This medication may affect the cardiovascular system, increasing the risk of thrombosis, myocardial infarction, and stroke. Patients with existing cardiovascular diseases or risk factors should exercise greater caution and monitor for cardiovascular symptoms closely during treatment. This drug can cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforation. These side effects may occur without warning symptoms during the treatment period, so elderly patients or those with a history of gastrointestinal diseases need to be particularly cautious. Severe skin reactions may occur, and if symptoms of a skin rash or hypersensitivity appear, discontinue use immediately and seek medical attention. This medication contains benzyl alcohol, which can cause life-threatening respiratory symptoms in premature infants; therefore, it should not be administered to them. Patients with a history of gastrointestinal ulcers, bleeding, or perforation, severe liver, kidney, or heart disease, and pregnant or breastfeeding individuals, should not use this medication. It is also not recommended for children and individuals over 80 years old. Patients with a history of peptic ulcers, blood disorders, liver dysfunction, renal dysfunction, heart failure, hypertension, and bronchial asthma should use this medication with caution and consult a doctor if there are concomitant medications. Various adverse reactions such as gastrointestinal symptoms, skin rashes, blood disorders, and changes in renal function may occur during use; if symptoms appear, inform medical personnel immediately. This medication should be used at the minimum effective dose for the shortest duration possible. Regular blood tests and checks of liver and kidney function are necessary during long-term use. This medication may prolong bleeding time, so patients at risk of bleeding should exercise caution and use appropriate antibacterial agents in case of infection. This drug should not be combined with other non-steroidal anti-inflammatory drugs, and since interactions may exist with certain medications, be sure to inform healthcare providers of any medications currently being taken. During pregnancy, especially in late stages, this medication may be harmful to the fetus and should not be used. It is also considered safer not to use while breastfeeding. In case of overdose, symptoms such as vomiting, drowsiness, nausea, gastrointestinal bleeding may occur, so immediate medical attention should be sought. Keep out of reach of children, and it is safe not to transfer it to another container.

• Gastrointestinal bleeding
• peptic ulcer
• hematemesis
• rectal bleeding
• epigastric pain
• stomach discomfort
• loss of appetite
• nausea
• vomiting
• diarrhea

This medication is sensitive to light; therefore, it should be stored in a light-resistant, sealed container. Additionally, to maintain the efficacy of the drug, it is important to store it at room temperature, between 1 degree and 30 degrees.

Appearance

Brown ampoule filled with light yellow liquid

Package unit

1mL/ampoule X 50 ampoules